Mari Kirishima Selected Research

Mari Kirishima Research Topics

Disease

13	Neoplasms (Cancer) 11/2023 - 01/2017
6	Glioblastoma (Glioblastoma Multiforme) 08/2023 - 01/2022
3	Neoplasm Metastasis (Metastasis) 04/2022 - 12/2019
2	Astrocytoma (Pilocytic Astrocytoma) 11/2022 - 09/2022
2	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 09/2021
2	Stomach Neoplasms (Stomach Cancer) 06/2022 - 04/2022
1	Paraganglioma (Paragangliomas) 03/2024
1	Sarcoma (Soft Tissue Sarcoma) 11/2023
1	Necrosis 08/2023
1	Anaplasia 08/2023
1	Glioma (Gliomas) 08/2023
1	Carcinogenesis 08/2023
1	Thrombosis (Thrombus) 07/2022
1	Microsatellite Instability 06/2022
1	Fatigue 06/2022
1	Lymphatic Metastasis 04/2022
1	Weight Loss (Weight Reduction) 04/2022
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2022
1	Neuroblastoma 12/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019
1	Hemorrhage 02/2018
1	Subependymal Glioma (Subependymoma) 02/2018
1	Aneurysm (Aneurysms) 11/2017
1	Carcinoma (Carcinomatosis) 06/2017
1	Adenocarcinoma 06/2017
1	Neurilemmoma (Schwannoma) 01/2017

Drug/Important Bio-Agent (IBA)

5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2023 - 09/2022
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2017
3	ErbB Receptors (EGF Receptor)IBA 08/2023 - 04/2022
2	Messenger RNA (mRNA)IBA 11/2023 - 08/2023
2	RNA (Ribonucleic Acid)IBA 08/2023 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 11/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2022 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 04/2022
2	Immune Checkpoint InhibitorsIBA 06/2022 - 02/2020
2	RamucirumabIBA 06/2022 - 04/2022
2	pembrolizumabIBA 06/2022 - 12/2019
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2022 - 01/2022
2	AntibodiesIBA 06/2017 - 01/2017
1	Capsules (Microcapsules)IBA 11/2023
1	Mucin-4IBA 11/2023
1	Carrier Proteins (Binding Protein)IBA 11/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2023
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2023
1	ElementsIBA 11/2023
1	epidermal growth factor receptor VIIIIBA 08/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	TensinsIBA 01/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 11/2022
1	Golgi Matrix ProteinsIBA 11/2022
1	TropomyosinIBA 11/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2022
1	Cyclin-Dependent Kinase 5IBA 11/2022
1	atezolizumabIBA 07/2022
1	Bevacizumab (Avastin)FDA Link 07/2022
1	VimentinIBA 05/2022
1	Imatinib Mesylate (Gleevec)FDA Link 05/2022
1	Therapeutic UsesIBA 05/2022
1	DesminIBA 05/2022
1	16S Ribosomal RNAIBA 01/2022
1	acarboxyprothrombin (PIVKA)IBA 09/2021
1	TOR Serine-Threonine KinasesIBA 09/2021
1	Tumor Biomarkers (Tumor Markers)IBA 09/2021
1	Differentiation AntigensIBA 12/2020
1	Monoclonal AntibodiesIBA 12/2019
1	Toll-Like Receptor AgonistsIBA 12/2019
1	Imiquimod (Aldara)FDA LinkGeneric 12/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2019
1	HemosiderinIBA 02/2018
1	CollagenIBA 11/2017
1	ParaffinIBA 06/2017
1	AntigensIBA 06/2017
1	MucinsIBA 06/2017
1	Collagen Type IV (Type IV Collagen)IBA 01/2017
1	S100 Proteins (S 100 Protein)IBA 01/2017

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2022
1	Hepatectomy 04/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 04/2022
1	Gastrectomy 04/2022
1	Mastectomy (Mammectomy) 01/2022
1	Molecular Targeted Therapy 01/2022